Reports

The global Anticoagulant Reversal Agent market was valued at 1205 million in 2025 and is projected to reach US$ 1958 million by 2032, at a CAGR of 7.3% during the forecast period.

The global Uterotonic Agent market was valued at 2219 million in 2025 and is projected to reach US$ 3159 million by 2032, at a CAGR of 5.1% during the forecast period.

The global Topical Recombinant Human Thrombin market was valued at 227 million in 2025 and is projected to reach US$ 418 million by 2032, at a CAGR of 9.2% during the forecast period.

The global Bone Morphogenetic Protein (BMP) 2 market was valued at 690 million in 2025 and is projected to reach US$ 1132 million by 2032, at a CAGR of 7.3% during the forecast period.

The global Antipyretic Chinese Traditional Medicine market was valued at 2976 million in 2025 and is projected to reach US$ 4874 million by 2032, at a CAGR of 7.4% during the forecast period.

The global Human Immumoglobulin (PH4) for Intravenous Injection market was valued at 11423 million in 2025 and is projected to reach US$ 20736 million by 2032, at a CAGR of 9.0% during the forecast period.

The global RNAi Therapeutics market was valued at 881 million in 2025 and is projected to reach US$ 3083 million by 2032, at a CAGR of 20.4% during the forecast period.

The global Feminine Care Gel market was valued at 1947 million in 2025 and is projected to reach US$ 2910 million by 2032, at a CAGR of 6.1% during the forecast period.

The global Amoxicillin Clavulanate Potassium API market was valued at 342 million in 2025 and is projected to reach US$ 509 million by 2032, at a CAGR of 5.8% during the forecast period.

The global Sodium Chloride Ophthalmic Solution market was valued at 78.30 million in 2025 and is projected to reach US$ 130 million by 2032, at a CAGR of 7.6% during the forecast period.